Wuhan Youngsen Biotech Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2009

Location

Wuhan hubei China

Primary Industry

Medical Devices & Equipment

About

Founded in 2009 and based in Wuhan, China, Wuhan Youngsen Biotech is a medical equipment manufacturer that focuses on research, development, and production of artificial blood vessel products. It has 1,000 square meters of GMP-compliant clean plant. The company has 20 invention patents, and awards honors including the National High-Tech Enterprises. In 2017, It participated in the national key research and development plan project. In June 2020, its YSVG-S02 Artificial Blood Vessel program began clinical trials. In February 2015, Wuhan Youngsen Biotech raised CNY 20 million in series A funding from new investor Shenzhen Capital Group. Youngsen Biotech's products include the artificial blood vessel VASCULAR GRAFT and the pathway triple-layer bionic small-caliber artificial blood vessel. The products are based on the structure of the human body's arteries.

Current Investors

Shenzhen Capital Real Estate Fund

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment

Website

www.youngsen.cn

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.